Published in NPJ Parkinsons Dis on April 10, 2017
Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk. Front Neurol (2017) 0.75
Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature (2010) 16.86
UniProt: a hub for protein information. Nucleic Acids Res (2014) 16.72
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry (1988) 14.72
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet (2008) 9.68
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet (2011) 9.10
Epidemiology of Parkinson's disease. Lancet Neurol (2006) 8.13
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Discovery and refinement of loci associated with lipid levels. Nat Genet (2013) 7.86
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2006) 7.32
High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet (2005) 6.86
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ (2010) 5.19
Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet (2008) 5.04
Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet (2011) 5.01
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26
Alzheimer's disease and Parkinson's disease. N Engl J Med (2003) 3.88
Parkinson's disease. Hum Mol Genet (2007) 3.84
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet (2010) 2.21
A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Ann Hum Genet (2009) 2.15
Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet (2011) 2.12
Genetics of Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.96
Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ (1998) 1.92
Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr (2013) 1.76
Prospective study of statin use and risk of Parkinson disease. Arch Neurol (2012) 1.76
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med (2007) 1.72
Vitamin D from different sources is inversely associated with Parkinson disease. Mov Disord (2014) 1.67
Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab (2005) 1.58
Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol (2006) 1.49
PRSice: Polygenic Risk Score software. Bioinformatics (2014) 1.42
Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. Am J Psychiatry (2011) 1.38
Genetics of Parkinson's disease--state of the art, 2013. Parkinsonism Relat Disord (2014) 1.38
Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet (2011) 1.36
Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study. Mov Disord (2008) 1.26
Genomewide association study for onset age in Parkinson disease. BMC Med Genet (2009) 1.24
Testosterone deficiency and apathy in Parkinson's disease: a pilot study. J Neurol Neurosurg Psychiatry (2004) 1.20
Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan. J Neurol Sci (2010) 1.18
Oxidative damage in Parkinson disease: Measurement using accurate biomarkers. Free Radic Biol Med (2009) 1.15
Genetics of Parkinson's disease: the yield. Parkinsonism Relat Disord (2014) 1.14
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem Sci (2015) 1.12
Statin use and the risk of Parkinson disease. Neurology (2008) 1.10
Genome wide assessment of young onset Parkinson's disease from Finland. PLoS One (2012) 1.09
Oxidative stress and Parkinson's disease. Front Neuroanat (2015) 1.08
Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol (2012) 1.07
Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK. Drug Saf (2008) 1.02
Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Arch Neurol (2006) 1.01
Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nat Commun (2014) 1.00
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet (2014) 0.95
Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov Disord (2015) 0.93
Statin use and Parkinson's disease in Denmark. Mov Disord (2010) 0.93
Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol (2002) 0.92
Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci Lett (2013) 0.92
Statin use and the risk of Parkinson disease: a nested case control study. J Clin Neurosci (2008) 0.92
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study. PLoS One (2013) 0.90
Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J Neuropathol Exp Neurol (2006) 0.88
Long-term statin use and the risk of Parkinson's disease. Am J Manag Care (2013) 0.87
Viral and inflammatory triggers of neurodegenerative diseases. Sci Transl Med (2012) 0.86
AKAPs integrate genetic findings for autism spectrum disorders. Transl Psychiatry (2013) 0.85
The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons. Neurobiol Aging (2015) 0.84
Orientation, distance, regulation and function of neighbouring genes. Hum Genomics (2009) 0.82
Protein aggregation in Parkinson's disease. Acta Neurol Scand Suppl (2010) 0.81
Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men. Steroids (2012) 0.80
Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease. Acta Neurol Belg (2012) 0.80
LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. Curr Med Res Opin (2005) 0.80
Plasma testosterone is associated with Framingham risk score. Aging Male (2012) 0.79
An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder. J Psychiatry Neurosci (2016) 0.78
Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease. Parkinsonism Relat Disord (2015) 0.78
The relation of testosterone levels with fatigue and apathy in Parkinson's disease. Clin Neurol Neurosurg (2009) 0.77
cGMP level in idiopathic Parkinson's disease patients with and without cardiovascular disease - A pilot study. Parkinsonism Relat Disord (2011) 0.76
Macronutrients intake and risk of Parkinson's disease: A meta-analysis. Geriatr Gerontol Int (2014) 0.75
Cardiometabolic factors and disease duration in patients with Parkinson's disease. Nutrition (2013) 0.75
Lysosomes to combat Parkinson's disease. Nat Neurosci (2015) 0.75
Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients. PLoS One (2013) 0.75